A detailed history of Jupiter Asset Management LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Jupiter Asset Management LTD holds 157,457 shares of ACAD stock, worth $2.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
157,457
Previous 1,060,840 85.16%
Holding current value
$2.7 Million
Previous $17.2 Million 85.94%
% of portfolio
0.02%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$15.14 - $19.14 $13.7 Million - $17.3 Million
-903,383 Reduced 85.16%
157,457 $2.42 Million
Q2 2024

Aug 08, 2024

SELL
$14.62 - $18.42 $7.94 Million - $10 Million
-542,934 Reduced 33.85%
1,060,840 $17.2 Million
Q1 2024

May 10, 2024

BUY
$17.79 - $30.86 $5.01 Million - $8.68 Million
281,410 Added 21.28%
1,603,774 $29.7 Million
Q4 2023

Feb 09, 2024

BUY
$20.78 - $31.77 $958,955 - $1.47 Million
46,148 Added 3.62%
1,322,364 $41.4 Million
Q3 2023

Nov 09, 2023

BUY
$20.84 - $33.47 $102,782 - $165,074
4,932 Added 0.39%
1,276,216 $26.6 Million
Q2 2023

Aug 10, 2023

SELL
$17.8 - $25.65 $1.71 Million - $2.47 Million
-96,317 Reduced 7.04%
1,271,284 $30.4 Million
Q1 2023

May 10, 2023

BUY
$16.32 - $20.92 $4.53 Million - $5.81 Million
277,629 Added 25.47%
1,367,601 $25.7 Million
Q4 2022

Feb 10, 2023

BUY
$14.2 - $18.63 $14.4 Million - $18.9 Million
1,012,680 Added 1310.2%
1,089,972 $17.4 Million
Q3 2022

Nov 10, 2022

BUY
$14.11 - $18.27 $173,172 - $224,227
12,273 Added 18.88%
77,292 $1.27 Million
Q2 2022

Aug 10, 2022

BUY
$13.01 - $27.22 $845,897 - $1.77 Million
65,019 New
65,019 $917,000
Q4 2020

Feb 10, 2021

SELL
$41.04 - $56.79 $4.77 Million - $6.6 Million
-116,258 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$36.42 - $57.0 $4.23 Million - $6.63 Million
116,258 New
116,258 $4.8 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.78B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.